Показать сокращенную информацию
dc.contributor.author | Khabibulina V. | |
dc.contributor.author | Yurchenko N. | |
dc.contributor.author | Korostelev S. | |
dc.contributor.author | Shashkina M. | |
dc.contributor.author | Sergeev A. | |
dc.date.accessioned | 2018-09-17T21:52:55Z | |
dc.date.available | 2018-09-17T21:52:55Z | |
dc.date.issued | 1997 | |
dc.identifier.issn | 0042-8809 | |
dc.identifier.uri | https://dspace.kpfu.ru/xmlui/handle/net/135558 | |
dc.description.abstract | Possibility of including of synthetic beta-carotene in variuos courses of chemotherapy of lympholeucosis of mice BDF1 was investigated. In experimental models cyclophosphan and platidiam (50, 100, 200 and 8 mg/kg b.w. respectively) was used as anticancer drugs. Beta-carotene (5, 10, 20, 50 mg/kg b.w.) was administrated to mice in different schemes. During experiments it was observed that beta-carotene does not effect the rapeutic action of cyclophósphan and platidiam during treatment of lympholeucosis L1210. | |
dc.relation.ispartofseries | Voprosy Meditsinskoj Khimii | |
dc.subject | Beta-carotene | |
dc.subject | Chemotherapy | |
dc.subject | Experimental models | |
dc.subject | Lympholeucosis | |
dc.title | Inclusion of beta-carotene in various courses of chemotherapy of lympholeucosis L1210 | |
dc.type | Article | |
dc.relation.ispartofseries-issue | 2 | |
dc.relation.ispartofseries-volume | 43 | |
dc.collection | Публикации сотрудников КФУ | |
dc.relation.startpage | 97 | |
dc.source.id | SCOPUS00428809-1997-43-2-SID5344258234 |